#1 Clinical Trials Search in Europe

Dutasteride

Dutasteride, a medication used to treat benign prostatic hyperplasia (BPH) and male pattern baldness, has been the subject of several clinical trials. These studies aim to evaluate its safety, efficacy, and potential applications in various prostate-related conditions. This article summarizes key findings from recent clinical trials investigating dutasteride’s use in different formulations and treatment scenarios.

Table of Contents

What is Dutasteride?

Dutasteride, also known by its brand names Avodart® and Duodart®, is a medication primarily used to treat conditions related to prostate enlargement and male pattern baldness[1]. It belongs to a class of drugs called 5-alpha-reductase inhibitors, which work by reducing the production of a hormone called dihydrotestosterone (DHT)[2].

Conditions Treated by Dutasteride

Dutasteride is primarily used to treat the following conditions:

  • Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause urinary problems in men[1].
  • Androgenetic Alopecia (AGA): Also known as male pattern baldness, this is a common form of hair loss in men[3].
  • Prostate Cancer: While not its primary use, some studies have investigated dutasteride’s potential in managing prostate cancer[5].

How Dutasteride Works

Dutasteride works by inhibiting the action of an enzyme called 5-alpha-reductase. This enzyme is responsible for converting testosterone into dihydrotestosterone (DHT). By reducing DHT levels, dutasteride can help:

  • Shrink an enlarged prostate, which can improve urinary symptoms in men with BPH[1].
  • Slow down or stop hair loss in men with androgenetic alopecia, as DHT is a key factor in male pattern baldness[3].
  • Potentially slow the growth of some prostate cancers, as DHT can stimulate cancerous growth in the prostate[5].

Dosage Forms and Administration

Dutasteride is typically available in the following forms:

  • Soft gelatin capsules: Usually containing 0.5 mg of dutasteride[1].
  • Combination capsules: Some formulations, like Duodart®, combine dutasteride (0.5 mg) with another medication called tamsulosin (0.4 mg)[4].

The typical dosage is one capsule taken orally once daily, with or without food. It’s important to swallow the capsule whole and not to chew or open it[4].

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of dutasteride:

  • For BPH: Long-term studies have shown that dutasteride can effectively reduce prostate size, improve urinary symptoms, and decrease the risk of acute urinary retention and the need for BPH-related surgery[1].
  • For Hair Loss: Studies have demonstrated that dutasteride can be effective in treating male pattern baldness, potentially even more so than another commonly used medication, finasteride[3].
  • For Prostate Cancer: Some research has investigated the potential of dutasteride in managing prostate cancer, particularly in men undergoing active surveillance for low-risk prostate cancer[5].

Side Effects and Safety

Like all medications, dutasteride can cause side effects. Common side effects may include:

  • Sexual side effects (such as decreased libido, erectile dysfunction, or ejaculation disorders)
  • Breast tenderness or enlargement
  • Dizziness

It’s important to note that these side effects are generally mild and may decrease over time. However, if you experience any persistent or severe side effects, you should consult your healthcare provider[1][4].

Other Potential Uses

While dutasteride is primarily used for BPH and male pattern baldness, researchers are exploring its potential in other areas:

  • Prostate Cancer Prevention: Some studies have investigated whether dutasteride could reduce the risk of developing prostate cancer in men at high risk[5].
  • Combination Therapy: Dutasteride is sometimes used in combination with other medications, such as tamsulosin, for enhanced effectiveness in treating BPH[4].

It’s important to note that the use of dutasteride for any condition should always be under the guidance and prescription of a healthcare professional.

Aspect Details
Study Types Bioequivalence studies, safety assessments, efficacy evaluations
Conditions Studied Benign Prostatic Hyperplasia (BPH), Androgenetic Alopecia, Prostate Cancer
Dosage Forms Soft gelatin capsules, novel formulations
Dose Ranges 0.05 mg to 2.5 mg, with 0.5 mg being common
Primary Outcomes PSA levels, prostate volume, urinary symptoms, pharmacokinetic parameters
Safety Assessments Adverse events, vital signs, laboratory tests, ECG measurements
Study Durations Ranging from short-term (weeks) to long-term (52 weeks or more)
Combination Therapies Studied with tamsulosin for BPH treatment

FAQ

  • What is dutasteride and how does it work? Dutasteride is a medication that inhibits the enzyme 5-alpha-reductase, which converts testosterone to dihydrotestosterone (DHT). By reducing DHT levels, it helps shrink the prostate gland and alleviate symptoms associated with benign prostatic hyperplasia (BPH).
  • What conditions is dutasteride being studied for in clinical trials? Clinical trials are investigating dutasteride for various conditions, including benign prostatic hyperplasia (BPH), androgenetic alopecia (male pattern baldness), and as part of active surveillance for favorable-risk prostate cancer.
  • How is dutasteride administered in these clinical trials? In the trials, dutasteride is typically administered orally as a soft gelatin capsule. Dosages range from 0.05 mg to 2.5 mg, with 0.5 mg being a common dose. Some studies are also exploring novel formulations and combination therapies.
  • What are the primary outcomes being measured in dutasteride clinical trials? The primary outcomes often include changes in prostate-specific antigen (PSA) levels, prostate volume, urinary symptoms, and safety assessments. Some trials also focus on pharmacokinetic parameters to evaluate bioequivalence of different formulations.
  • How long do these clinical trials typically last? The duration of dutasteride clinical trials varies widely. Some short-term studies last a few weeks, while others, particularly those investigating long-term effects, can extend up to 52 weeks or more. Follow-up periods may also be included after the treatment phase.

Ongoing Clinical Trials on Dutasteride

  • Study on the Effectiveness of Dutasteride with Goserelin Acetate and Bicalutamide in Patients with Recurrent or Metastatic Salivary Duct Carcinoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

Glossary

  • Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms in older men.
  • Prostate-Specific Antigen (PSA): A protein produced by the prostate gland. Elevated levels may indicate prostate conditions, including cancer.
  • Androgenetic Alopecia: Also known as male pattern baldness, a common form of hair loss in men caused by genetic and hormonal factors.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Bioequivalence: The absence of a significant difference in the rate and extent at which the active ingredient in pharmaceutical equivalents becomes available at the site of drug action.
  • 5-alpha-reductase: An enzyme that converts testosterone to dihydrotestosterone (DHT), which is involved in prostate growth and male pattern baldness.
  • Dihydrotestosterone (DHT): A potent androgen hormone derived from testosterone that plays a role in prostate growth and hair loss.
  • Active Surveillance: A monitoring approach for low-risk prostate cancer that involves regular check-ups and tests instead of immediate treatment.
  • Gleason Score: A grading system used to determine the aggressiveness of prostate cancer based on the microscopic appearance of cancer cells.
  • PSA Doubling Time: The time it takes for the PSA level to double, which can be used to assess the progression of prostate conditions.

References

  1. https://clinicaltrials.gov/study/NCT00969072
  2. https://clinicaltrials.gov/study/NCT01577693
  3. https://clinicaltrials.gov/study/NCT01929330
  4. https://clinicaltrials.gov/study/NCT01657851
  5. https://clinicaltrials.gov/study/NCT01525914